Literature DB >> 19799860

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides.

Xiuling Li1, Chunming Mao, Shujun Ma, Xiaoqing Wang, Zhe Sun, Yao Yi, Minzhuo Guo, Xinliang Shen, Le Sun, Shengli Bi.   

Abstract

Enterovirus 71 (EV71) has led to recent outbreaks of hand, foot and mouth disease (HFMD) in China, resulting in high mortality. In this study, several monoclonal antibodies were generated by immunizing mice with two synthetic peptides, SP55 and SP70, containing amino acids 163-177 and 208-222 of VP1. The specificities of the anti-EV71 peptide monoclonal antibodies were confirmed by Western blot analysis and immunocytochemistry against EV71 virus. Most importantly, we have identified a monoclonal antibody, clone 22A12, which shows strong neutralizing activity against EV71 in an in vitro neutralization assay. Because there is no vaccine available and treatment is very limited, mouse anti-EV71 monoclonal antibody, clone 22A12, could be a promising candidate to be humanized and used for treatment of EV71 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799860     DOI: 10.1016/j.bbrc.2009.09.103

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Genetic analysis of the P1 region of human enterovirus 71 strains and expression of the 55 F strainVP1 protein.

Authors:  Jian-qiang Li; Jun-jie Yang; Xiu-juan Fan; Zhen-peng Sun; Yan Sun; Huan Li; Zi-xin Meng; Wei Li
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

2.  Development of a sandwich ELISA for the quantification of enterovirus 71.

Authors:  Shujun Ma; Qunying Mao; Zhenglun Liang; Cuijuan Zhang; Wenxing Yang; Zhe Sun; Haijiang Zhang; Xinliang Shen; Shengli Bi; Le Sun
Journal:  Cytotechnology       Date:  2013-06-02       Impact factor: 2.058

3.  Monoclonal neutralizing antibodies against EV71 screened from mice immunized with yeast-produced virus-like particles.

Authors:  Tao Lin; Lingzhi Xianyu; Songya Lyu
Journal:  Virol Sin       Date:  2015-05-29       Impact factor: 4.327

4.  Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris.

Authors:  Zhijian Yang; Fan Gao; Xiaoliang Wang; Likang Shi; Zheng Zhou; Yuanxiang Jiang; Xinxing Ma; Chao Zhang; Chenliang Zhou; Xianfang Zeng; Ge Liu; Jiang Fan; Qunying Mao; Li Shi
Journal:  Hum Vaccin Immunother       Date:  2019-08-15       Impact factor: 3.452

Review 5.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

6.  Preparation and characterization of monoclonal antibodies against VSTM1.

Authors:  Ting Li; Wenyan Wang; Yingyu Chen; Wenling Han
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-08

7.  The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro.

Authors:  Kristin L Shingler; Javier O Cifuente; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

8.  A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody.

Authors:  Hyunwook Lee; Javier O Cifuente; Robert E Ashley; James F Conway; Alexander M Makhov; Yoshio Tano; Hiroyuki Shimizu; Yorihiro Nishimura; Susan Hafenstein
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

9.  Enterovirus-A71 Rhombencephalitis Outbreak in Catalonia: Characteristics, Management and Outcome.

Authors:  Núria Wörner; Rocío Rodrigo-García; Andrés Antón; Ester Castellarnau; Ignacio Delgado; Èlida Vazquez; Sebastià González; Lluís Mayol; Maria Méndez; Eduard Solé; Jaume Rosal; Cristina Andrés; Alejandro Casquero; Esther Lera; Mónica Sancosmed; Magda Campins; Tomàs Pumarola; Carlos Rodrigo
Journal:  Pediatr Infect Dis J       Date:  2021-07-01       Impact factor: 2.129

10.  Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.

Authors:  Xingui Tian; Xiaobo Su; Xiao Li; Haitao Li; Ting Li; Zhichao Zhou; Tianhua Zhong; Rong Zhou
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.